Alignment Healthcare, Inc. reported first‑quarter 2026 revenue of $1.23 billion, a 33.3% year‑over‑year increase from $926.9 million in Q1 2025. Net income rose to $11.4 million, turning a $9.4 million loss into a profit and delivering earnings per share of $0.05, a $0.04 beat over the consensus estimate of $0.01.
Membership grew to 284,800, up 31% from 217,000 in the prior year, driven by strong enrollment in high‑acuity plans such as C‑SNP, LIS, and dual‑eligible segments. The medical benefits ratio improved to 88.2% from 89.3%, reflecting tighter medical cost control and a more favorable member mix.
The turnaround from a $9.4 million loss in Q1 2025 to a $11.4 million profit in Q1 2026 underscores the effectiveness of the company’s care‑management model. The diluted loss per share of $0.05 in 2025 was replaced by a $0.05 EPS in 2026, illustrating a full reversal of the prior‑year earnings decline.
Management reiterated full‑year 2026 revenue guidance of $5.16 billion to $5.205 billion, an increase from the previous $5.16 billion to $5.20 billion range, and maintained a positive outlook for adjusted EBITDA. The company highlighted its embedded gross‑profit potential, noting that more than half of its members are in early cohorts that can drive future margin expansion without additional membership growth.
The earnings beat and raised guidance prompted a mixed market reaction, with analysts upgrading the stock to a strong‑buy rating. The company’s ability to convert a prior‑year loss into a profit and to improve its medical benefits ratio signals strong operational execution and confidence in its Medicare Advantage model.
Management acknowledged a temporary workflow disruption that caused higher acute‑rate authorizations in January, which was resolved by the end of February. The company continues to invest in technology, automation, and AI to drive efficiency and margin expansion, while navigating regulatory changes and competitive pressures in the Medicare Advantage market.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.